November 13-14 2025

Lyon, France

Program

This edition will feature the following themes:

  • Alternative to current antibiotics & antivirals
  • Immunotherapies & new biotherapeutics
  • One Health Approach to Tackling Infectious Diseases
  • Innovations in human vaccines
  • AI & Data-Driven Strategies for Infectious Diseases
  • Innovative Biomarkers for Infectious Diseases: From Diagnosis to Theragnosis

2025 Speaker

Erin Duffy

Chief of Research & Development

CARB-X, USA

Lisa Osbelt-Block

Researcher

Helmholtz Center for Infection Research, Germany

Vincent Marechal

Professor

Sorbonne University

Director

National platform OBEPINE+

Mélanie Hamon

Head of the Chromatin and Infection group

Institut Pasteur, France

Helen Bright

CSO

Centauri Therapeutics, United Kingdom

Nicolas Burdin

Global Head of R&D

CloverBiopharmaceuticals, France

Victoria Savage

CSO

Infex Therapeutics Ltd, United Kingdom

Stuart Hannah

CEO

Microplate Dx, Scotland

Khaled Abousaleh

CEO

Zynnon, Switzerland

DAY 1

Thursday, 13 November 2025

8h00

Registration & welcome coffee

8h30

Welcome Address

8h35

Title to be confirmed

Mabdesign

Elsa Kress

Head of Business Development

MabDesign, France

8h45

Opening lectures

- Plenary

Chaired by

8h45

Title to be confirmed

Richard White

Professor of Infectious Disease Modelling

London School of Hygiene and Tropical Medicine, United Kingdom

9h15

Modelling to support new TB Vaccine development and (hopefully) introduction

Richard White

Professor of Infectious Disease Modelling

London School of Hygiene and Tropical Medicine, United Kingdom

9h45

Decoding Mycobacterium tuberculosis Diversity: Unlocking New Strategies in TB Control

Sarah Fortune

Chair of Immunology and Infectious Diseases

Harvard T.H. Chan School of Public Health, USA

10h15

Title to be confirmed

Maria Van Kerkhove

Director (a.i.) Department of Epidemic and Pandemic Preparedness and Prevention

World Health Organization, Switzerland

10h45

Coffe Break - Exhibition Hall

11h05

Track 1: One Health Approach to Tackling Infectious Diseases

- Plenary

Chaired by

11h05

OH should be embedded in health policies and strategies

Thierry Lefrançois

Advisor to the CEO

CIRAD, France

11h35

OBEPINE+ platform: tracking epidemics through wastewater analysis

Vincent Marechal

Professor of virology

Sorbonne University, France

Director

National platform OBEPINE+, France

11h55

Novel vaccines for the control of highly avian influenza in poultry

Agnès Dancer

R&D Project Manager

Boehringer Ingelheim, France

11h25

Speaker 3

Yves Briers

CSO

Obulytix - Belgium

12h15

Q&A session

12h25

Lunchbreak - Poster Presentation - B2B Meetings

14h00

Track 2: Innovations in human vaccines

- Plenary

Sponsored by Sanofi

Chaired by

14h00

Clover’s Trimer-Tag vaccines: COVID, RSV and beyond…

Nicolas Burdin

Global Head of R&D

Clover Biopharmaceuticals, France

14h40

The transformative role of open-access adjuvants for human vaccines

Céline Lemoine

Head of VFI Laboratories

Vaccine Formulation Institute (VFI) - Switzerland

15h00

Speaker 4

Stephanie Fanucchi

CSO

Lemba Therapeutics - Netherlands

15h20

Q&A session

15h35

Coffe Break - Exhibition Hall - B2B Meetings 3 slots

16h10

Driving Breakthroughs in Infectious Diseases

16h10

Establishment of a Comprehensive Platform for Empowering the Discovery of Viral Vaccines

Fusen Lin

Research Director

WuXi AppTec - China

16h25

Addressing Delivery Barriers in RNA-based Vaccines through the FlashRNA® Platform

Christine Duthoit

CEO - CSO

RNAlead - France

16h40

ViroID- Breakthrough Approach to Viral Characterization through Nanopore Technology

Léa Chazot-Franguiadakis

Research Engineer

Ecole Normale Supérieure de Lyon - France

16h50

nanoSFERIC: A Novel Flexible Nanoparticle Vaccine Platform

Urban Bezeljak

CEO

Sferogen - Slovenia

17h00

Expanding the Toolbox for Passive Immunotherapy: Comparative Evaluation of Purified, LNP-RNA, and rAAV Antibody Delivery

David Torres

Preclinical Analytics Project Leader

CER Groupe - Belgium

17h10

Discovery and preclinical development of potent human neutralizing antibodies against BK polyomavirus for prophylactic use in kidney transplant recipients

Pascal Poignard

University professor and hospital practitioner

Institut de Biologie Structurale (IBS) - France

17h20

Peptide microarrays as a novel high-throughput tool for mapping HLA class II–peptide interactions - a case study on HCMV epitopes

Dagmar Hildebrand

Head of R&D

PEPperPRINT - Germany

17h30

OVX836, a Nucleoprotein-based vaccine under clinical development, offers protection Against Highly Pathogenic Avian Influenza Viruses (H5N1 and H7N9) in Mouse and Ferret Models

Charlotte Primard

Senior non clinical project manager

Osivax - France

17h40

Real-time Immunological Profiling in Physiological Conditions: Advancing Vaccine and Therapeutic Development with WHITE FOx Technology

Florian Bossard

Scientific Sales Manager

Vixen Bio - France

17h50

Real-Time Detection of Ligand Interactions on Live Bacteria: A Kinetic Study of Antibody Binding

Joao Encarnação

Founder

Adamastor Bioservices - Italy

18h00

From Pathogen Load to Host Response: A Bioluminescent Human Pulmonary ALI Model of KAPE Bacteria for Translational Antimicrobial Screening

Marc Vandamme

R&D program director

ERBC - France

18h10

Evening Cocktail & Networking

18h00

End of DAY 1

DAY 2

Friday, 14 November 2025

8h15

Welcome coffee

8h45

Opening lectures

- Plenary

Chaired by

8h45

Title to be confirmed

Marco Cavaleri

Head of Public Health Threats

European Medicines Agency - Netherlands

9h15

Fighting Antimicrobial Resistance Through Innovation

Vega Masignani

Alliance Director

CARB-X, USA

9h45

Roundtable: Pandemic Preparedness: Threats, Surveillance, and Healthcare Readiness

- Plenary

Animated by IDCluster

Christiane Riedel

Specialist in veterinary medicine and virology

ENS/CIRI, Senegal

Christiane Riedel

Specialist in veterinary medicine and virology

ENS/CIRI, France

Mawlouth Diallo

Head of Unit

Institut Pasteur de Dakar, Senegal

Xavier Lescure

Infectious disease specialist

Hôpital Bichat Claude-Bernard, France

10h30

Coffe Break - Exhibition Hall - B2B Meetings

11h00

Track 3: Immunotherapies & new biotherapeutics

- Plenary

Chaired by

11h00

How bacterial pathogens manipulate host chromatin to modulate immune responses?

Mélanie Hamon

Head of the Chromatin and Infection group

Institut Pasteur, France

11h20

Alphamer®: A Modular Antibody-Recruiting Platform for Infectious Disease

David Chapman

Head of Biology

Centauri Therapeutics, United Kingdom

11h40

RESP-X: A Novel Anti-Virulence Therapy Targeting Pseudomonas aeruginosa in Chronic Infection

Victoria Savage

CSO

Infex Therapeutics Ltd, United Kingdom

12h00

Q&A session

12h15

Lunchbreak - Poster Presentation - B2B Meetings

14h00

Track 4: Alternative to current antibiotics & antivirals

- Plenary

Chaired by

14h00

Competition in the gut: From ecology to novel therapeutics

Lisa Osbelt-Block

Researcher

Helmholtz Center for Infection Research, Germany

14h20

Small Molecule FPR1 Agonists: Boosting the Innate Immune System to Cure Resistant Bacterial Infections

Peter Olofsson-Sahl

Founder and CEO

Inicure AB, Sweden

14h40

RNAs in bacteria-phage interactions: from identification to applications for biotechnology and health

Olga Soutourina

Professor in Microbiology

Paris-Saclay University - France

15h00

Q&A session

15h15

Track 5: Innovative Biomarkers for Infectious Diseases: From Diagnosis to Theragnosis

- Plenary

Chaired by

15h15

RapidPlateTM: A novel, cost-effective, electrochemical, rapid antibiotic susceptibility test for urinary tract infections

Stuart Hannah

CEO

Microplate Dx, Scotland

15h40

Revolutionizing Infectious Disease Diagnostics Through Gas Signatures

Khaled Abousaleh

CEO

Zynnon, Switzerland

15h55

Speaker 3

Antonella Comforti

Principal Investigator

Takis Biotech - Italy

16h05

Track 6: AI & Data-Driven Strategies for Infectious Diseases

- Plenary

Chaired by

15h05

Agentic AI from Biology to Drug Discovery

Maxime Touzot

Head of Medicine

Owkin, France

16h30

Annoucemment of next year edition

16h40

End of CONGRESS